Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod

Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod

Source: 
Xconomy
snippet: 

An Esperion Therapeutics drug that pairs two cholesterol-lowering medicines in a single pill has been approved by the FDA, the second regulatory nod for the company in less than a week.